ID   CXB1_HUMAN              Reviewed;         283 AA.
AC   P08034; B2R8R2; D3DVV2; Q5U0S4;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1988, sequence version 1.
DT   21-MAR-2012, entry version 138.
DE   RecName: Full=Gap junction beta-1 protein;
DE   AltName: Full=Connexin-32;
DE            Short=Cx32;
DE   AltName: Full=GAP junction 28 kDa liver protein;
GN   Name=GJB1; Synonyms=CX32;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   MEDLINE=86304555; PubMed=2875078; DOI=10.1083/jcb.103.3.767;
RA   Kumar N.M., Gilula N.B.;
RT   "Cloning and characterization of human and rat liver cDNAs coding for
RT   a gap junction protein.";
RL   J. Cell Biol. 103:767-776(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-17.
RA   Neuhaus I.M., Bone L., Wang S., Ionasescu V., Werner R.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   TOPOLOGY.
RX   MEDLINE=89030588; PubMed=2460334;
RA   Milks L.C., Kumar N.M., Houghten R., Unwin N., Gilula N.B.;
RT   "Topology of the 32-kd liver gap junction protein determined by site-
RT   directed antibody localizations.";
RL   EMBO J. 7:2967-2975(1988).
RN   [8]
RP   3D-STRUCTURE MODELING OF 19-209, AND STRUCTURE BY ELECTRON
RP   CRYOMICROSCOPY (20 ANGSTROMS).
RX   PubMed=15383278; DOI=10.1016/j.molcel.2004.08.016;
RA   Fleishman S.J., Unger V.M., Yeager M., Ben-Tal N.;
RT   "A Calpha model for the transmembrane alpha helices of gap junction
RT   intercellular channels.";
RL   Mol. Cell 15:879-888(2004).
RN   [9]
RP   REVIEW ON CMTX1 VARIANTS.
RX   MEDLINE=99103460; PubMed=9888385;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.3.CO;2-1;
RA   Nelis E., Haites N., van Broeckhoven C.;
RT   "Mutations in the peripheral myelin genes and associated genes in
RT   inherited peripheral neuropathies.";
RL   Hum. Mutat. 13:11-28(1999).
RN   [10]
RP   VARIANTS CMTX1 SER-12; MET-139; TRP-142; ARG-156; SER-172 AND LYS-186.
RX   MEDLINE=94090344; PubMed=8266101; DOI=10.1126/science.8266101;
RA   Bergoffen J., Schere S.S., Wang S., Oronzi Scott M., Bone L.J.,
RA   Paul D.L., Chen K., Lensch M.W., Chance P.F., Fischbeck K.H.;
RT   "Connexin mutations in X-linked Charcot-Marie-Tooth disease.";
RL   Science 262:2039-2042(1993).
RN   [11]
RP   VARIANTS CMTX1 MET-35; ALA-158; THR-182 AND 111-HIS--HIS-116 DEL.
RA   Cherryson A.K., Yeung L., Kennerson M.L., Nicholson G.A.;
RT   "Mutational studies in X-linked Charcot-Marie-Tooth disease (CMTX).";
RL   Am. J. Hum. Genet. 55:A216-A216(1994).
RN   [12]
RP   VARIANTS CMTX1 GLN-15; PHE-60; ILE-63; LEU-143 DEL; LYS-208 AND
RP   TRP-215.
RX   MEDLINE=94214471; PubMed=8162049; DOI=10.1093/hmg/3.1.29;
RA   Fairweather N., Bell C., Cochrane S., Chelly J., Wang S.,
RA   Mostacciuolo M.L., Monaco A.P., Haites N.E.;
RT   "Mutations in the connexin 32 gene in X-linked dominant Charcot-Marie-
RT   Tooth disease (CMTX1).";
RL   Hum. Mol. Genet. 3:29-34(1994).
RN   [13]
RP   VARIANTS CMTX1 GLY-102 AND TRP-142.
RX   MEDLINE=94272480; PubMed=8004109; DOI=10.1093/hmg/3.2.355;
RA   Ionasescu V., Searby C., Ionasescu R.;
RT   "Point mutations of the connexin32 (GJB1) gene in X-linked dominant
RT   Charcot-Marie-Tooth neuropathy.";
RL   Hum. Mol. Genet. 3:355-358(1994).
RN   [14]
RP   VARIANT CMTX1 MET-38.
RX   MEDLINE=95135434; PubMed=7833935; DOI=10.1093/hmg/3.9.1699;
RA   Orth U., Fairweather N., Exler M.-C., Schwinger E., Gal A.;
RT   "X-linked dominant Charcot-Marie-Tooth neuropathy: valine-38-
RT   methionine substitution of connexin32.";
RL   Hum. Mol. Genet. 3:1699-1700(1994).
RN   [15]
RP   VARIANTS CMTX1 LEU-13; ASN-30; CYS-65; MET-95; ARG-133 AND ARG-156.
RX   MEDLINE=96022165; PubMed=7477983;
RA   Bone L.J., Dahl N., Lensch M.W., Chance P.F., Kelly T., le Guern E.,
RA   Magi S., Parry G., Shapiro H., Wang S., Fischbeck K.H.;
RT   "New connexin32 mutations associated with X-linked Charcot-Marie-Tooth
RT   disease.";
RL   Neurology 45:1863-1866(1995).
RN   [16]
RP   VARIANTS CMTX1 SER-3; GLN-22; SER-77; ARG-80; GLY-102; TRP-142 AND
RP   TRP-164.
RX   MEDLINE=96363805; PubMed=8737658;
RX   DOI=10.1002/(SICI)1096-8628(19960614)63:3<486::AID-AJMG14>3.0.CO;2-I;
RA   Ionasescu V., Ionasescu R., Searby C.;
RT   "Correlation between connexin 32 gene mutations and clinical phenotype
RT   in X-linked dominant Charcot-Marie-Tooth neuropathy.";
RL   Am. J. Med. Genet. 63:486-491(1996).
RN   [17]
RP   VARIANTS CMTX1 GLY-22; PRO-22 AND TRP-215.
RX   MEDLINE=96305443; PubMed=8698335; DOI=10.1007/s004390050183;
RA   Ressot C., Latour P., Blanquet-Grossard F., Sturtz F., Duthel S.,
RA   Battin J., Corbillon E., Ollagnon E., Serville F., Vandenberghe A.,
RA   Dautigny A., Pham-Dinh D.;
RT   "X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new
RT   mutations in the connexin32 gene.";
RL   Hum. Genet. 98:172-175(1996).
RN   [18]
RP   VARIANTS CMTX1 THR-34; GLN-75 AND TRP-107.
RX   MEDLINE=96233937; PubMed=8829637;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:2<167::AID-HUMU14>3.3.CO;2-#;
RA   Tan C.C., Ainsworth P.J., Hahn A.F., Macleod P.M.;
RT   "Novel mutations in the connexin 32 gene associated with X-linked
RT   Charcot-Marie tooth disease.";
RL   Hum. Mutat. 7:167-171(1996).
RN   [19]
RP   VARIANT CMTX1 CYS-7.
RX   MEDLINE=96400967; PubMed=8807343;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:1<83::AID-HUMU14>3.3.CO;2-#;
RA   Schiavon F., Fracasso C., Mostacciuolo M.L.;
RT   "Novel missense mutation of the connexin32 (GJB1) gene in X-linked
RT   dominant Charcot-Marie-Tooth neuropathy.";
RL   Hum. Mutat. 8:83-84(1996).
RN   [20]
RP   VARIANTS CMTX1 LEU-26 AND SER-53.
RX   MEDLINE=97044517; PubMed=8889588;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:3<270::AID-HUMU12>3.3.CO;2-G;
RA   Yoshimura T., Ohnishi A., Yamamoto T., Fukushima Y., Kitani M.,
RA   Kobayashi T.;
RT   "Two novel mutations (C53S, S26L) in the connexin32 of Charcot-Marie-
RT   Tooth disease type X families.";
RL   Hum. Mutat. 8:270-272(1996).
RN   [21]
RP   VARIANT CMTX1 SER-3.
RX   MEDLINE=97114297; PubMed=8956046;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:4<375::AID-HUMU14>3.3.CO;2-Q;
RA   Gupta S., Benstead T., Neumann P., Guernsey D.;
RT   "A point mutation in codon 3 of connexin-32 is associated with X-
RT   linked Charcot-Marie-Tooth neuropathy.";
RL   Hum. Mutat. 8:375-376(1996).
RN   [22]
RP   VARIANT CMTX1 TRP-164.
RX   MEDLINE=96311679; PubMed=8733054;
RA   Oterino A., Monton F.I., Cabrera V.M., Pinto F., Gonzalez A.,
RA   Lavilla N.R.;
RT   "Arginine-164-tryptophan substitution in connexin32 associated with X
RT   linked dominant Charcot-Marie-Tooth disease.";
RL   J. Med. Genet. 33:413-415(1996).
RN   [23]
RP   VARIANT CMT-X TYR-49.
RX   MEDLINE=96212566; PubMed=8628473;
RA   Timmerman V., de Jonghe P., Spoelders P., Simokovic S., Loefgren A.,
RA   Nelis E., Vance J., Martin J.-J., van Broeckhoven C.;
RT   "Linkage and mutation analysis of Charcot-Marie-Tooth neuropathy type
RT   2 families with chromosomes 1p35-p36 and Xq13.";
RL   Neurology 46:1311-1318(1996).
RN   [24]
RP   VARIANTS CMT-X VAL-34; HIS-90; TRP-107; TRP-142; PHE-156 AND LYS-186.
RX   MEDLINE=97170727; PubMed=9018031;
RA   Latour P., Fabreguette A., Ressot C., Blanquet-Grossard F.,
RA   Antoine J.-C., Calvas P., Chapon F., Corbillon E., Ollagnon E.,
RA   Sturtz F., Boucherat M., Chazot G., Dautigny A., Pham-Dinh D.,
RA   Vandenberghe A.;
RT   "New mutations in the X-linked form of Charcot-Marie-Tooth disease.";
RL   Eur. Neurol. 37:38-42(1997).
RN   [25]
RP   VARIANTS CMT-X TRP-15; ILE-63; CYS-65; SER-87; PRO-89; MET-139 AND
RP   ARG-199.
RX   MEDLINE=97254431; PubMed=9099841; DOI=10.1007/s004390050396;
RA   Janssen E.A.M., Kemp S., Hensels G.W., Sie O.G.,
RA   de Die-Smulders C.E.M., Hoogendijk J.E., de Visser M., Bolhuis P.A.;
RT   "Connexin32 gene mutations in X-linked dominant Charcot-Marie-Tooth
RT   disease (CMTX1).";
RL   Hum. Genet. 99:501-505(1997).
RN   [26]
RP   VARIANTS CMT-X ALA-23; SER-64; SER-87; TRP-164; GLN-164; SER-183;
RP   HIS-183; CYS-183 AND TRP-215.
RX   MEDLINE=97331335; PubMed=9187667; DOI=10.1007/s004390050442;
RA   Bort S., Nelis E., Timmerman V., Sevilla T., Cruz-Martinez A.,
RA   Martinez F., Millan J.M., Arpa J., Vilchez J.J., Prieto F.,
RA   van Broeckhoven C., Palau F.;
RT   "Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of
RT   Spanish ancestry with Charcot-Marie-Tooth disease and hereditary
RT   neuropathy with liability to pressure palsies.";
RL   Hum. Genet. 99:746-754(1997).
RN   [27]
RP   VARIANTS CMT-X GLN-22; GLN-75; TRP-75; TRY-107; MET-139 AND VAL-194.
RX   MEDLINE=97418124; PubMed=9272161; DOI=10.1007/s004390050522;
RA   Silander K., Meretoja P., Pihko H., Juvonen V., Issakainen J.,
RA   Aula P., Savontaus M.L.;
RT   "Screening for connexin 32 mutations in Charcot-Marie-Tooth disease
RT   families with possible X-linked inheritance.";
RL   Hum. Genet. 100:391-397(1997).
RN   [28]
RP   VARIANTS CMT-X PHE-25; LEU-26; ALA-87 AND HIS-238.
RX   MEDLINE=97144182; PubMed=8990008;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.3.CO;2-N;
RA   Nelis E., Simokovic S., Timmerman V., Loefgren A., Backhovens H.,
RA   de Jonghe P., Martin J.-J., Van Broeckhoven C.;
RT   "Mutation analysis of the connexin 32 (Cx32) gene in Charcot-Marie-
RT   Tooth neuropathy type 1: identification of five new mutations.";
RL   Hum. Mutat. 9:47-52(1997).
RN   [29]
RP   VARIANTS THR-34; ILE-84; MET-95; TRP-107; ARG-133; LEU-141; ALA-158;
RP   ASN-203; SER-205 AND 213-ILE-ILE-214 DELINS LEU.
RX   MEDLINE=98062179; PubMed=9401007;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:6<443::AID-HUMU5>3.3.CO;2-K;
RA   Rouger H., Leguern E., Birouk N., Gouider R., Tardieu S., Plassart E.,
RA   Gugenheim M., Vallat J.-M., Louboutin J.-P., Bouche P., Agid Y.,
RA   Brice A.;
RT   "Charcot-Marie-Tooth disease with intermediate motor nerve conduction
RT   velocities: characterization of 14 Cx32 mutations in 35 families.";
RL   Hum. Mutat. 10:443-452(1997).
RN   [30]
RP   VARIANTS CMT-X ARG-3; SER-3; CYS-7; SER-12; LEU-13; MET-13; LYS-14;
RP   GLN-15; TRP-15; PRO-16; SER-20; ASP-21; GLN-22; PRO-22; GLY-22;
RP   ALA-23; PHE-25; LEU-26; ASN-28; THR-28; LEU-29; ASN-30; THR-34;
RP   VAL-34; MET-35; MET-38; VAL-40; LYS-41; LEU-44; TYR-49; SER-53;
RP   PHE-56; PHE-60; ILE-63; SER-64; CYS-65; GLN-75; PRO-75; TRP-75;
RP   SER-77; ARG-80; CYS-85; PHE-85; ALA-86; ASN-86; SER-86; ALA-87;
RP   LEU-87; SER-87; PRO-89; HIS-90; VAL-93; GLN-94; TYR-94; MET-95;
RP   TYR-100; GLY-102; GLU-103; TRP-107; HIS-111--116-HIS DEL; ASN-124;
RP   PRO-128; ARG-133; MET-139; TRP-142; GLU-142; LEU-143 DEL; ARG-156;
RP   PHE-156; CYS-157; ALA-158; ARG-158; HIS-160; PRO-161; TRP-164;
RP   GLN-164; SER-172; LEU-172; TYR-178; ARG-179; LEU-180; MET-181;
RP   THR-182; CYS-183; SER-183; HIS-183; THR-185 DEL; LYS-186; GLU-187;
RP   GLY-189; ILE-189; 191-THR--PHE-193 DEL; CYS-193; PHE-198; ARG-199;
RP   ARG-201; VAL-204; SER-205; LYS-208; TRP-215; CYS-219; HIS-219;
RP   GLY-220; CYS-230; LEU-230; CYS-235 AND HIS-238.
RX   MEDLINE=98027204; PubMed=9361298; DOI=10.1006/nbdi.1997.0152;
RA   Bone L.J., Deschenes S.M., Balice-Gordon R.J., Fischbeck K.H.,
RA   Scherer S.S.;
RT   "Connexin32 and X-linked Charcot-Marie-Tooth disease.";
RL   Neurobiol. Dis. 4:221-230(1997).
RN   [31]
RP   VARIANTS CMT-X PRO-22; GLY-22; VAL-34; PRO-50; PHE-56; TRP-75; HIS-90;
RP   TRP-107; ARG-133; TRP-142; PHE-156; SER-159; ARG-184; LYS-186 AND
RP   TRP-215.
RX   MEDLINE=20194951; PubMed=10732813; DOI=10.1007/s100480050017;
RA   Latour P., Levy N., Paret M., Chapon F., Chazot G., Clavelou P.,
RA   Couratier P., Dumas R., Ollagnon E., Pouget J., Setiey A.,
RA   Vallat J.-M., Boucherat M., Fontes M., Vandenberghe A.;
RT   "Mutations in the X-linked form of Charcot-Marie-Tooth disease in the
RT   French population.";
RL   Neurogenetics 1:117-123(1997).
RN   [32]
RP   VARIANTS CMT-X MET-37; HIS-57; LEU-172 AND ALA-177.
RX   PubMed=9856562;
RX   DOI=10.1002/(SICI)1096-8628(19981204)80:4<352::AID-AJMG9>3.0.CO;2-R;
RA   Ikegami T., Lin C., Kato M., Itoh A., Nonaka I., Kurimura M.,
RA   Hirayabashi H., Shinohara Y., Mochizuki A., Hayasaka K.;
RT   "Four novel mutations of the connexin 32 gene in four Japanese
RT   families with Charcot-Marie-Tooth disease type 1.";
RL   Am. J. Med. Genet. 80:352-355(1998).
RN   [33]
RP   VARIANTS CMT-X SER-3; GLN-22; ALA-70; SER-77; ARG-80; MET-95; GLY-102;
RP   TRP-142; TRP-164 AND SER-180.
RX   PubMed=10873293; DOI=10.1006/cbir.1998.0387;
RA   Ionasescu V.V.;
RT   "X-linked Charcot-Marie-Tooth disease and connexin32.";
RL   Cell Biol. Int. 22:807-813(1998).
RN   [34]
RP   VARIANT CMT-X ARG-201.
RX   MEDLINE=98112404; PubMed=9452025;
RA   Sillen A., Anneren G., Dahl N.;
RT   "A novel mutation (C201R) in the transmembrane domain of connexin 32
RT   in severe X-linked Charcot-Marie-Tooth disease.";
RL   Hum. Mutat. Suppl. 1:S8-S9(1998).
RN   [35]
RP   VARIANTS CMT-X TRP-15; PHE-60; ALA-86; TYR-100; CYS-133 AND SER-205.
RX   MEDLINE=98112478; PubMed=9452099;
RA   Sorour E., Upadhyaya M.;
RT   "Mutation analysis in Charcot-Marie-Tooth disease type 1 (CMT1).";
RL   Hum. Mutat. Suppl. 1:S242-S247(1998).
RN   [36]
RP   VARIANTS CMT-X GLN-22; ARG-58; ILE-63; LEU-172; ASP-175 AND PHE-204.
RX   MEDLINE=98295578; PubMed=9633821;
RX   DOI=10.1002/(SICI)1098-1004(1998)12:1<59::AID-HUMU9>3.3.CO;2-1;
RA   Silander K., Meretoja P., Juvonen V., Ignatius J., Pihko H.,
RA   Saarinen A., Wallden T., Herrgaard E., Aula P., Savontaus M.-L.;
RT   "Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth
RT   disease and related neuropathies.";
RL   Hum. Mutat. 12:59-68(1998).
RN   [37]
RP   VARIANTS CMT-X SER-53 AND ARG-172, AND CHARACTERIZATION OF VARIANTS
RP   CMT-X SER-53 AND ARG-172.
RX   PubMed=9469569;
RX   DOI=10.1002/(SICI)1097-4547(19980115)51:2<154::AID-JNR4>3.0.CO;2-C;
RA   Yoshimura T., Satake M., Ohnishi A., Tsutsumi Y., Fujikura Y.;
RT   "Mutations of connexin32 in Charcot-Marie-Tooth disease type X
RT   interfere with cell-to-cell communication but not cell proliferation
RT   and myelin-specific gene expression.";
RL   J. Neurosci. Res. 51:154-161(1998).
RN   [38]
RP   VARIANTS CMT-X TRP-9; GLN-22; THR-28; THR-30; THR-34; MET-35; TRP-107;
RP   MET-127; PRO-131; ALA-158; THR-182; PHE-192 AND ILE-239.
RX   PubMed=9818870;
RA   Nicholson G.A., Yeung L., Corbett A.;
RT   "Efficient neurophysiologic selection of X-linked Charcot-Marie-Tooth
RT   families: ten novel mutations.";
RL   Neurology 51:1412-1416(1998).
RN   [39]
RP   VARIANTS CMT-X GLN-22; VAL-39; MET-43; PHE-60; THR-104; MET-139;
RP   GLN-142; TRP-142; VAL-149 AND GLU-177.
RX   PubMed=10586284; DOI=10.1111/j.1749-6632.1999.tb08621.x;
RA   Williams M.M., Tyfield L.A., Jardine P., Lunt P.W., Stevens D.L.,
RA   Turnpenny P.D.;
RT   "HMSN and HNPP. Laboratory service provision in the south west of
RT   England -- two years' experience.";
RL   Ann. N. Y. Acad. Sci. 883:500-503(1999).
RN   [40]
RP   VARIANTS CMT-X ILE-55; GLU-120 AND GLN-164.
RX   MEDLINE=99235561; PubMed=10220155;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<339::AID-HUMU18>3.0.CO;2-S;
RA   Karadimas C., Panas M., Chronopoulou P., Avramopoulos D.,
RA   Vassilopoulos D.;
RT   "Three novel mutations in the gap junction beta 1 (GJB1) gene coding
RT   region identified in Charcot-Marie-Tooth patients of Greek origin:
RT   T55I, R164Q, V120E.";
RL   Hum. Mutat. 13:339-339(1999).
RN   [41]
RP   VARIANT CMT-X SER-205.
RX   PubMed=10071100;
RA   Baehr M., Andres F., Timmerman V., Nelis M.E., Van Broeckhoven C.,
RA   Dichgans J.;
RT   "Central visual, acoustic, and motor pathway involvement in a Charcot-
RT   Marie-Tooth family with an Asn205Ser mutation in the connexin 32
RT   gene.";
RL   J. Neurol. Neurosurg. Psych. 66:202-206(1999).
RN   [42]
RP   CHARACTERIZATION OF VARIANTS CMT-X LYS-208; GLN-215; TRP-215; HIS-238
RP   AND GLY-280.
RX   PubMed=10234007;
RA   Castro C., Gomez-Hernandez J.M., Silander K., Barrio L.C.;
RT   "Altered formation of hemichannels and gap junction channels caused by
RT   C-terminal connexin-32 mutations.";
RL   J. Neurosci. 19:3752-3760(1999).
RN   [43]
RP   VARIANTS CMT-X MET-91 AND HIS-211.
RX   PubMed=11140841; DOI=10.1034/j.1399-0004.2000.580511.x;
RA   Bissar-Tadmouri N., Parman Y., Boutrand L., Deymeer F., Serdaroglu P.,
RA   Vandenberghe A., Battaloglu E.;
RT   "Mutational analysis and genotype/phenotype correlation in Turkish
RT   Charcot-Marie-Tooth type 1 and HNPP patients.";
RL   Clin. Genet. 58:396-402(2000).
RN   [44]
RP   VARIANT CMT-X TYR-126.
RX   PubMed=11030070; DOI=10.1053/ejpn.2000.0311;
RA   Verhelst H.E., Lofgren A., Van Coster R.N.;
RT   "A family with X-linked dominant Charcot-Marie-Tooth caused by a
RT   connexin32 mutation.";
RL   Eur. J. Paediatr. Neurol. 4:235-238(2000).
RN   [45]
RP   VARIANT CMT-X ARG-59.
RX   PubMed=10894999; DOI=10.1159/000008196;
RA   Felice K.J., Seltzer W.K.;
RT   "Severe X-linked Charcot-Marie-Tooth neuropathy due to new mutations
RT   [G59R(G-->C), W44X(G-->A)] in the connexin 32 gene.";
RL   Eur. Neurol. 44:61-63(2000).
RN   [46]
RP   VARIANTS CMT-X 20-ASN-SER-21; LYS-34; ARG-80; VAL-90; VAL-93; TRP-107;
RP   TRP-142; GLN-164; HIS-183; LYS-186; LEU-193 AND LYS-208.
RX   PubMed=10737979;
RX   DOI=10.1002/(SICI)1098-1004(200004)15:4<340::AID-HUMU6>3.3.CO;2-P;
RA   Mersiyanova I.V., Ismailov S.M., Polyakov A.V., Dadali E.L.,
RA   Fedotov V.P., Nelis E., Loefgren A., Timmerman V., Van Broeckhoven C.,
RA   Evgrafov O.V.;
RT   "Screening for mutations in the peripheral myelin genes PMP22, MPZ and
RT   Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.";
RL   Hum. Mutat. 15:340-347(2000).
RN   [47]
RP   ERRATUM.
RA   Mersiyanova I.V., Ismailov S.M., Polyakov A.V., Dadali E.L.,
RA   Fedotov V.P., Nelis E., Loefgren A., Timmerman V., Van Broeckhoven C.,
RA   Evgrafov O.V.;
RL   Hum. Mutat. 16:175-175(2000).
RN   [48]
RP   VARIANTS CMT-X LEU-69; GLN-142 AND GLN-164.
RX   PubMed=10923043;
RX   DOI=10.1002/1098-1004(200008)16:2<177::AID-HUMU14>3.0.CO;2-5;
RA   Yoshihara T., Yamamoto M., Doyu M., Misu K., Hattori N., Hasegawa Y.,
RA   Mokuno K., Mitsuma T., Sobue G.;
RT   "Mutations in the peripheral myelin protein zero and connexin32 genes
RT   detected by non-isotopic RNase cleavage assay and their phenotypes in
RT   Japanese patients with Charcot-Marie-Tooth disease.";
RL   Hum. Mutat. 16:177-178(2000).
RN   [49]
RP   VARIANT CMT-X ILE-8.
RX   PubMed=10938190; DOI=10.1007/s100720070105;
RA   Di Iorio G., Cappa V., Ciccodicola A., Sampaolo S., Ammendola A.,
RA   Sanges G., Giugliano R., D'Urso M.;
RT   "A new de novo mutation of the connexin-32 gene in a patient with X-
RT   linked Charcot-Marie-Tooth type 1 disease.";
RL   Neurol. Sci. 21:109-112(2000).
RN   [50]
RP   VARIANTS CMT-X GLY-22; THR-34; VAL-34; PHE-56; ILE-84; MET-91; ASP-94;
RP   GLN-94; MET-95; TRP-107; ILE-130; ARG-133; LEU-141; GLN-142; ALA-158;
RP   ASP-159; TRP-164; GLN-164; LYS-186; ARG-199; ASN-203; SER-205;
RP   213-ILE-ILE-214 DELINS LEU AND TRP-215, AND CHARACTERIZATION OF
RP   VARIANTS CMT-X GLY-22; THR-34; PHE-56; GLN-94; MET-95; LYS-186 AND
RP   TRP-215.
RX   PubMed=11571214; DOI=10.1093/brain/124.10.1958;
RA   Dubourg O., Tardieu S., Birouk N., Gouider R., Leger J.M.,
RA   Maisonobe T., Brice A., Bouche P., LeGuern E.;
RT   "Clinical, electrophysiological and molecular genetic characteristics
RT   of 93 patients with X-linked Charcot-Marie-Tooth disease.";
RL   Brain 124:1958-1967(2001).
RN   [51]
RP   VARIANT CMT-X GLY-208.
RX   PubMed=11180613;
RX   DOI=10.1002/1098-1004(200102)17:2<157::AID-HUMU22>3.0.CO;2-E;
RA   Kochanski A., Lofgren A., Jedrzejowska H., Ryniewicz B.,
RA   Czarny-Ratajczak M., Barciszewska A.-M., Samocko J.,
RA   Hausmanowa-Petrusewicz I., De Jonghe P., Timmerman V.,
RA   Latos-Bielenska A.;
RT   "A novel connexin 32 missense mutation (E208G) causing Charcot-Marie-
RT   Tooth disease.";
RL   Hum. Mutat. 17:157-157(2001).
RN   [52]
RP   VARIANTS CMT-X CYS-7; PRO-8; GLN-22; PRO-25; ASN-30; CYS-59; MET-139;
RP   LEU-143 DEL; SER-151; TRP-164 AND LEU-184.
RX   PubMed=11438991; DOI=10.1002/humu.1147;
RA   Mostacciuolo M.L., Righetti E., Zortea M., Bosello V., Schiavon F.,
RA   Vallo L., Merlini L., Siciliano G., Fabrizi G.M., Rizzuto N.,
RA   Milani M., Baratta S., Taroni F.;
RT   "Charcot-Marie-Tooth disease type I and related demyelinating
RT   neuropathies: mutation analysis in a large cohort of Italian
RT   families.";
RL   Hum. Mutat. 18:32-41(2001).
RN   [53]
RP   VARIANT CMT-X HIS-65.
RX   MEDLINE=21446530; PubMed=11562788;
RA   Seeman P., Mazanec R., Ctvrteckova M., Smilkova D.;
RT   "Charcot-Marie-Tooth type X: a novel mutation in the Cx32 gene with
RT   central conduction slowing.";
RL   Int. J. Mol. Med. 8:461-468(2001).
RN   [54]
RP   VARIANTS CMT-X TRP-26; PHE-64; TRP-142; TRP-164 AND TRP-215.
RX   PubMed=11437164; DOI=10.1007/s004150170183;
RA   Young P., Grote K., Kuhlenbaeumer G., Debus O., Kurlemann H.,
RA   Halfter H., Funke H., Ringelstein E.B., Stoegbauer F.;
RT   "Mutation analysis in Chariot-Marie Tooth disease type 1: point
RT   mutations in the MPZ gene and the GJB1 gene cause comparable
RT   phenotypic heterogeneity.";
RL   J. Neurol. 248:410-415(2001).
RN   [55]
RP   VARIANT CMTX1 ILE-55.
RX   PubMed=11723288;
RA   Panas M., Kalfakis N., Karadimas C., Vassilopoulos D.;
RT   "Episodes of generalized weakness in two sibs with the C164T mutation
RT   of the connexin 32 gene.";
RL   Neurology 57:1906-1908(2001).
RN   [56]
RP   VARIANTS CMTX1 TRP-15; GLN-22; GLY-102; PRO-108; ILE-205 AND TRP-215.
RX   MEDLINE=21823270; PubMed=11835375; DOI=10.1002/ana.10089;
RA   Boerkoel C.F., Takashima H., Garcia C.A., Olney R.K., Johnson J.,
RA   Berry K., Russo P., Kennedy S., Teebi A.S., Scavina M., Williams L.L.,
RA   Mancias P., Butler I.J., Krajewski K., Shy M., Lupski J.R.;
RT   "Charcot-Marie-Tooth disease and related neuropathies: mutation
RT   distribution and genotype-phenotype correlation.";
RL   Ann. Neurol. 51:190-201(2002).
RN   [57]
RP   VARIANTS CMTX1 TRP-142 AND TYR-168.
RX   PubMed=12325071; DOI=10.1002/ana.10305;
RA   Paulson H.L., Garbern J.Y., Hoban T.F., Krajewski K.M., Lewis R.A.,
RA   Fischbeck K.H., Grossman R.I., Lenkinski R., Kamholz J.A., Shy M.E.;
RT   "Transient central nervous system white matter abnormality in X-linked
RT   Charcot-Marie-Tooth disease.";
RL   Ann. Neurol. 52:429-434(2002).
RN   [58]
RP   VARIANTS CMTX1 TRP-75; GLN-75; VAL-120 DEL; MET-139; LYS-146; ASP-147;
RP   VAL-209 DEL AND CYS-264.
RX   PubMed=12402337; DOI=10.1002/humu.10134;
RA   Numakura C., Lin C., Ikegami T., Guldberg P., Hayasaka K.;
RT   "Molecular analysis in Japanese patients with Charcot-Marie-Tooth
RT   disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.";
RL   Hum. Mutat. 20:392-398(2002).
RN   [59]
RP   VARIANTS CMTX1 CYS-24; ARG-55; ASP-125 AND SER-153.
RX   PubMed=12185164; DOI=10.1136/jnnp.73.3.304;
RA   Lee M.-J., Nelson I., Houlden H., Sweeney M.G., Hilton-Jones D.,
RA   Blake J., Wood N.W., Reilly M.M.;
RT   "Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth
RT   disease.";
RL   J. Neurol. Neurosurg. Psych. 73:304-306(2002).
RN   [60]
RP   CHARACTERIZATION OF VARIANTS CMTX ILE-34; LYS-34; THR-34; VAL-34;
RP   MET-35; MET-37; MET-38; VAL-40; GLN-75; PRO-75; TRP-75; ILE-205;
RP   VAL-213; CYS-219; HIS-219; GLY-220; CYS-230; LEU-230; HIS-238 AND
RP   ILE-239.
RX   PubMed=12460545; DOI=10.1006/nbdi.2002.0545;
RA   Yum S.W., Kleopa K.A., Shumas S., Scherer S.S.;
RT   "Diverse trafficking abnormalities of connexin32 mutants causing
RT   CMTX.";
RL   Neurobiol. Dis. 11:43-52(2002).
RN   [61]
RP   VARIANT CMTX1 THR-40.
RX   PubMed=12536289; DOI=10.1007/s100720200061;
RA   Ma W., Farrukh Nizam M., Grewal R.P.;
RT   "X-linked Charcot-Marie-Tooth disease caused by a novel point mutation
RT   in the connexin-32 gene.";
RL   Neurol. Sci. 23:195-197(2002).
RN   [62]
RP   VARIANT CMTX1 PRO-49.
RX   PubMed=12207932; DOI=10.1016/S0960-8966(02)00021-4;
RA   Street V.A., Meekins G., Lipe H.P., Seltzer W.K., Carter G.T.,
RA   Kraft G.H., Bird T.D.;
RT   "Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel
RT   mutations in the MPZ and Cx 32 genes.";
RL   Neuromuscul. Disord. 12:643-650(2002).
RN   [63]
RP   CHARACTERIZATION OF VARIANT CMTX1 CYS-85.
RX   PubMed=11891346; DOI=10.1073/pnas.261713499;
RA   Abrams C.K., Bennett M.V.L., Verselis V.K., Bargiello T.A.;
RT   "Voltage opens unopposed gap junction hemichannels formed by a
RT   connexin 32 mutant associated with X-linked Charcot-Marie-Tooth
RT   disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:3980-3984(2002).
RN   [64]
RP   VARIANT CMTX1 GLU-102 DEL.
RX   PubMed=12707076; DOI=10.1001/archneur.60.4.605;
RA   Hanemann C.O., Bergmann C., Senderek J., Zerres K., Sperfeld A.-D.;
RT   "Transient, recurrent, white matter lesions in X-linked Charcot-Marie-
RT   Tooth disease with novel connexin 32 mutation.";
RL   Arch. Neurol. 60:605-609(2003).
RN   [65]
RP   VARIANTS CMTX1 LEU-26; ALA-55; HIS-57; ILE-63; LEU-69; MET-139;
RP   GLN-142; TRP-142; ARG-172; ALA-177; HIS-183; ALA-191 AND TYR-201.
RX   PubMed=12477701; DOI=10.1093/brain/awg012;
RG   The study group for hereditary neuropathy in Japan;
RA   Hattori N., Yamamoto M., Yoshihara T., Koike H., Nakagawa M.,
RA   Yoshikawa H., Ohnishi A., Hayasaka K., Onodera O., Baba M., Yasuda H.,
RA   Saito T., Nakashima K., Kira J., Kaji R., Oka N., Sobue G.;
RT   "Demyelinating and axonal features of Charcot-Marie-Tooth disease with
RT   mutations of myelin-related proteins (PMP22, MPZ and Cx32): a
RT   clinicopathological study of 205 Japanese patients.";
RL   Brain 126:134-151(2003).
RN   [66]
RP   VARIANTS CMTX1 7-TYR-THR-8 DELINS SER; ASN-138; GLN-164; ALA-172 AND
RP   SER-205.
RX   PubMed=12497641; DOI=10.1002/humu.9101;
RA   Huehne K., Benes V., Thiel C., Kraus C., Kress W., Hoeltzenbein M.,
RA   Ploner C.J., Kotzian J., Reis A., Rott H.D., Rautenstrauss B.W.;
RT   "Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ,
RT   and GJB1.";
RL   Hum. Mutat. 21:100-100(2003).
RN   [67]
RP   VARIANTS CMTX1 GLY-102 AND ALA-181, AND CHARACTERIZATION OF VARIANTS
RP   CMTX1 GLY-102 AND ALA-181.
RX   PubMed=14627639;
RA   Abrams C.K., Freidin M., Bukauskas F., Dobrenis K., Bargiello T.A.,
RA   Verselis V.K., Bennett M.V.L., Chen L., Sahenk Z.;
RT   "Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential
RT   effects of two mutations in connexin 32.";
RL   J. Neurosci. 23:10548-10558(2003).
RN   [68]
RP   VARIANTS CMTX1 ALA-136; GLN-164 AND ARG-168.
RX   PubMed=15241803; DOI=10.1002/humu.9261;
RA   Choi B.-O., Lee M.S., Shin S.H., Hwang J.H., Choi K.-G., Kim W.-K.,
RA   Sunwoo I.N., Kim N.K., Chung K.W.;
RT   "Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean
RT   Charcot-Marie-Tooth neuropathy patients.";
RL   Hum. Mutat. 24:185-186(2004).
RN   [69]
RP   ERRATUM.
RA   Choi B.-O., Lee M.S., Shin S.H., Hwang J.H., Choi K.-G., Kim W.-K.,
RA   Sunwoo I.N., Kim N.K., Chung K.W.;
RL   Hum. Mutat. 24:350-350(2004).
RN   [70]
RP   VARIANT CMTX1 CYS-235, AND CHARACTERIZATION OF VARIANT CMTX1 CYS-235.
RX   PubMed=15852376; DOI=10.1002/ana.20459;
RA   Liang G.S.L., de Miguel M., Gomez-Hernandez J.M., Glass J.D.,
RA   Scherer S.S., Mintz M., Barrio L.C., Fischbeck K.H.;
RT   "Severe neuropathy with leaky connexin32 hemichannels.";
RL   Ann. Neurol. 57:749-754(2005).
RN   [71]
RP   VARIANT CMTX1 SER-127.
RX   PubMed=15468313; DOI=10.1002/mus.20166;
RA   Vondracek P., Seeman P., Hermanova M., Fajkusova L.;
RT   "X-linked Charcot-Marie-Tooth disease: phenotypic expression of a
RT   novel mutation Ile127Ser in the GJB1 (connexin 32) gene.";
RL   Muscle Nerve 31:252-255(2005).
RN   [72]
RP   VARIANT CMTX1 ALA-136.
RX   PubMed=15947997; DOI=10.1007/s10048-005-0217-4;
RA   Chung K.W., Sunwoo I.N., Kim S.M., Park K.D., Kim W.-K., Kim T.S.,
RA   Koo H., Cho M., Lee J., Choi B.O.;
RT   "Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot-
RT   Marie-Tooth disease family.";
RL   Neurogenetics 6:159-163(2005).
CC   -!- FUNCTION: One gap junction consists of a cluster of closely packed
CC       pairs of transmembrane channels, the connexons, through which
CC       materials of low MW diffuse from one cell to a neighboring cell.
CC   -!- SUBUNIT: A connexon is composed of a hexamer of connexins.
CC       Interacts with CNST (By similarity).
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC       Cell junction, gap junction.
CC   -!- DISEASE: Defects in GJB1 are the cause of Charcot-Marie-Tooth
CC       disease X-linked type 1 (CMTX1) [MIM:302800]; also designated CMT-
CC       X. CMTX1 is a form of Charcot-Marie-Tooth disease, the most common
CC       inherited disorder of the peripheral nervous system. Charcot-
CC       Marie-Tooth disease is classified in two main groups on the basis
CC       of electrophysiologic properties and histopathology: primary
CC       peripheral demyelinating neuropathies characterized by severely
CC       reduced motor nerve conduction velocities (NCVs) (less than 38m/s)
CC       and segmental demyelination and remyelination, and primary
CC       peripheral axonal neuropathies characterized by normal or mildly
CC       reduced NCVs and chronic axonal degeneration and regeneration on
CC       nerve biopsy. CMTX1 has both demyelinating and axonal features.
CC       Central nervous system involvement may occur.
CC   -!- DISEASE: Defects in GJB1 may contribute to the phenotype of
CC       Dejerine-Sottas syndrome (DSS) [MIM:145900]; also known as
CC       Dejerine-Sottas neuropathy (DSN) or hereditary motor and sensory
CC       neuropathy III (HMSN3). DSS is a severe degenerating neuropathy of
CC       the demyelinating Charcot-Marie-Tooth disease category, with onset
CC       by age 2 years. DSS is characterized by motor and sensory
CC       neuropathy with very slow nerve conduction velocities, increased
CC       cerebrospinal fluid protein concentrations, hypertrophic nerve
CC       changes, delayed age of walking as well as areflexia. There are
CC       both autosomal dominant and autosomal recessive forms of Dejerine-
CC       Sottas syndrome.
CC   -!- SIMILARITY: Belongs to the connexin family. Beta-type (group I)
CC       subfamily.
CC   -!- WEB RESOURCE: Name=Inherited peripheral neuropathies mutation db;
CC       URL="http://www.molgen.ua.ac.be/CMTMutations/";
CC   -!- WEB RESOURCE: Name=Connexin-deafness homepage;
CC       URL="http://davinci.crg.es/deafness/";
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/GJB1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04325; CAA27856.1; -; mRNA.
DR   EMBL; AK313474; BAG36259.1; -; mRNA.
DR   EMBL; BT019329; AAV38136.1; -; mRNA.
DR   EMBL; CH471132; EAX05305.1; -; Genomic_DNA.
DR   EMBL; CH471132; EAX05306.1; -; Genomic_DNA.
DR   EMBL; BC002805; AAH02805.1; -; mRNA.
DR   EMBL; BC022426; AAH22426.1; -; mRNA.
DR   EMBL; BC039198; AAH39198.1; -; mRNA.
DR   EMBL; L47127; AAA75086.1; -; Genomic_DNA.
DR   IPI; IPI00027190; -.
DR   PIR; B29005; B29005.
DR   RefSeq; NP_000157.1; NM_000166.5.
DR   RefSeq; NP_001091111.1; NM_001097642.2.
DR   UniGene; Hs.333303; -.
DR   PDB; 1TXH; Model; -; A/B/C/D/E/F=19-209.
DR   PDBsum; 1TXH; -.
DR   ProteinModelPortal; P08034; -.
DR   SMR; P08034; 2-215.
DR   STRING; P08034; -.
DR   TCDB; 1.A.24.1.3; gap junction-forming connexin family.
DR   PhosphoSite; P08034; -.
DR   DMDM; 117688; -.
DR   PRIDE; P08034; -.
DR   DNASU; 2705; -.
DR   Ensembl; ENST00000361726; ENSP00000354900; ENSG00000169562.
DR   Ensembl; ENST00000374022; ENSP00000363134; ENSG00000169562.
DR   Ensembl; ENST00000374029; ENSP00000363141; ENSG00000169562.
DR   GeneID; 2705; -.
DR   KEGG; hsa:2705; -.
DR   UCSC; uc004dzf.2; human.
DR   CTD; 2705; -.
DR   GeneCards; GC0XP070435; -.
DR   H-InvDB; HIX0016860; -.
DR   HGNC; HGNC:4283; GJB1.
DR   HPA; CAB012994; -.
DR   HPA; HPA010663; -.
DR   MIM; 145900; phenotype.
DR   MIM; 302800; phenotype.
DR   MIM; 304040; gene.
DR   neXtProt; NX_P08034; -.
DR   Orphanet; 101075; X-linked Charcot-Marie-Tooth disease type 1.
DR   PharmGKB; PA28694; -.
DR   eggNOG; NOG39645; -.
DR   GeneTree; ENSGT00620000087685; -.
DR   HOGENOM; HBG717760; -.
DR   HOVERGEN; HBG009576; -.
DR   InParanoid; P08034; -.
DR   KO; K07620; -.
DR   OMA; SSEYKQN; -.
DR   OrthoDB; EOG4PVP0F; -.
DR   PhylomeDB; P08034; -.
DR   Reactome; REACT_11123; Membrane Trafficking.
DR   NextBio; 10692; -.
DR   ArrayExpress; P08034; -.
DR   Bgee; P08034; -.
DR   CleanEx; HS_GJB1; -.
DR   Genevestigator; P08034; -.
DR   GermOnline; ENSG00000169562; Homo sapiens.
DR   GO; GO:0005922; C:connexon complex; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:0016044; P:cellular membrane organization; TAS:Reactome.
DR   GO; GO:0016264; P:gap junction assembly; TAS:Reactome.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   InterPro; IPR000500; Connexin.
DR   InterPro; IPR002267; Connexin32.
DR   InterPro; IPR019570; Connexin_CCC.
DR   InterPro; IPR017990; Connexin_CS.
DR   InterPro; IPR013092; Connexin_N.
DR   PANTHER; PTHR11984; Connexin; 1.
DR   Pfam; PF00029; Connexin; 1.
DR   Pfam; PF10582; Connexin_CCC; 1.
DR   PRINTS; PR00206; CONNEXIN.
DR   PRINTS; PR01138; CONNEXINB1.
DR   SMART; SM00037; CNX; 1.
DR   SMART; SM01089; Connexin_CCC; 1.
DR   PROSITE; PS00407; CONNEXINS_1; 1.
DR   PROSITE; PS00408; CONNEXINS_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane;
KW   Charcot-Marie-Tooth disease; Complete proteome;
KW   Dejerine-Sottas syndrome; Disease mutation; Gap junction; Membrane;
KW   Neuropathy; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    283       Gap junction beta-1 protein.
FT                                /FTId=PRO_0000057849.
FT   TOPO_DOM      1     22       Cytoplasmic (Probable).
FT   TRANSMEM     23     45       Helical; (Probable).
FT   TOPO_DOM     46     75       Extracellular (Probable).
FT   TRANSMEM     76     95       Helical; (Probable).
FT   TOPO_DOM     96    130       Cytoplasmic (Probable).
FT   TRANSMEM    131    153       Helical; (Probable).
FT   TOPO_DOM    154    191       Extracellular (Probable).
FT   TRANSMEM    192    214       Helical; (Probable).
FT   TOPO_DOM    215    283       Cytoplasmic (Probable).
FT   MOD_RES     258    258       Phosphoserine (By similarity).
FT   MOD_RES     266    266       Phosphoserine (By similarity).
FT   VARIANT       3      3       W -> R (in CMTX1).
FT                                /FTId=VAR_002006.
FT   VARIANT       3      3       W -> S (in CMTX1).
FT                                /FTId=VAR_002007.
FT   VARIANT       7      8       YT -> S (in CMTX1).
FT                                /FTId=VAR_029894.
FT   VARIANT       7      7       Y -> C (in CMTX1).
FT                                /FTId=VAR_002008.
FT   VARIANT       8      8       T -> I (in CMTX1).
FT                                /FTId=VAR_029895.
FT   VARIANT       8      8       T -> P (in CMTX1).
FT                                /FTId=VAR_002009.
FT   VARIANT       9      9       L -> W (in CMTX1).
FT                                /FTId=VAR_029896.
FT   VARIANT      11     11       S -> G (in CMTX1).
FT                                /FTId=VAR_002010.
FT   VARIANT      12     12       G -> S (in CMTX1).
FT                                /FTId=VAR_002011.
FT   VARIANT      13     13       V -> L (in CMTX1).
FT                                /FTId=VAR_002012.
FT   VARIANT      13     13       V -> M (in CMTX1).
FT                                /FTId=VAR_002013.
FT   VARIANT      14     14       N -> K (in CMTX1).
FT                                /FTId=VAR_002014.
FT   VARIANT      15     15       R -> Q (in CMTX1).
FT                                /FTId=VAR_002015.
FT   VARIANT      15     15       R -> W (in CMTX1; moderate).
FT                                /FTId=VAR_002016.
FT   VARIANT      16     16       H -> P (in CMTX1).
FT                                /FTId=VAR_002017.
FT   VARIANT      20     21       IG -> NS (in CMTX1).
FT                                /FTId=VAR_029897.
FT   VARIANT      20     20       I -> S (in CMTX1).
FT                                /FTId=VAR_002018.
FT   VARIANT      21     21       G -> D (in CMTX1).
FT                                /FTId=VAR_002019.
FT   VARIANT      22     22       R -> G (in CMTX1; non-functional
FT                                channel).
FT                                /FTId=VAR_002020.
FT   VARIANT      22     22       R -> P (in CMTX1).
FT                                /FTId=VAR_002021.
FT   VARIANT      22     22       R -> Q (in CMTX1; can be associated with
FT                                Ile-63).
FT                                /FTId=VAR_002022.
FT   VARIANT      23     23       V -> A (in CMTX1).
FT                                /FTId=VAR_002023.
FT   VARIANT      24     24       W -> C (in CMTX1).
FT                                /FTId=VAR_029898.
FT   VARIANT      25     25       L -> F (in CMTX1).
FT                                /FTId=VAR_002024.
FT   VARIANT      25     25       L -> P (in CMTX1).
FT                                /FTId=VAR_029899.
FT   VARIANT      26     26       S -> L (in CMTX1).
FT                                /FTId=VAR_002025.
FT   VARIANT      26     26       S -> W (in CMTX1; severe).
FT                                /FTId=VAR_029900.
FT   VARIANT      28     28       I -> IIF (in CMTX1).
FT                                /FTId=VAR_002027.
FT   VARIANT      28     28       I -> N (in CMTX1).
FT                                /FTId=VAR_029901.
FT   VARIANT      28     28       I -> T (in CMTX1).
FT                                /FTId=VAR_002026.
FT   VARIANT      29     29       F -> L (in CMTX1).
FT                                /FTId=VAR_002028.
FT   VARIANT      30     30       I -> N (in CMTX1).
FT                                /FTId=VAR_002029.
FT   VARIANT      30     30       I -> T (in CMTX1).
FT                                /FTId=VAR_029902.
FT   VARIANT      34     34       M -> I (in CMTX1; localized in the Golgi
FT                                apparatus but also forming rare small
FT                                junction-like plaques).
FT                                /FTId=VAR_029903.
FT   VARIANT      34     34       M -> K (in CMTX1; localized to the
FT                                endoplasmic reticulum).
FT                                /FTId=VAR_029904.
FT   VARIANT      34     34       M -> T (in CMTX1; functional channel;
FT                                localized in the Golgi apparatus without
FT                                reaching the cell membrane).
FT                                /FTId=VAR_002030.
FT   VARIANT      34     34       M -> V (in CMTX1; localized in the Golgi
FT                                apparatus but also forming rare small gap
FT                                junction-like plaques).
FT                                /FTId=VAR_002031.
FT   VARIANT      35     35       V -> M (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002032.
FT   VARIANT      37     37       V -> M (in CMTX1; localized in the Golgi
FT                                apparatus but also forming rare small gap
FT                                junction-like plaques).
FT                                /FTId=VAR_029905.
FT   VARIANT      38     38       V -> M (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_002033.
FT   VARIANT      39     39       A -> P (in CMTX1).
FT                                /FTId=VAR_002034.
FT   VARIANT      39     39       A -> V (in CMTX1).
FT                                /FTId=VAR_002035.
FT   VARIANT      40     40       A -> T (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_029906.
FT   VARIANT      40     40       A -> V (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_002036.
FT   VARIANT      41     41       E -> K (in CMTX1).
FT                                /FTId=VAR_002037.
FT   VARIANT      43     43       V -> M (in CMTX1).
FT                                /FTId=VAR_002038.
FT   VARIANT      44     44       W -> L (in CMTX1).
FT                                /FTId=VAR_002039.
FT   VARIANT      49     49       S -> P (in CMTX1).
FT                                /FTId=VAR_029907.
FT   VARIANT      49     49       S -> Y (in CMTX1).
FT                                /FTId=VAR_002040.
FT   VARIANT      50     50       S -> P (in CMTX1).
FT                                /FTId=VAR_002041.
FT   VARIANT      53     53       C -> S (in CMTX1; suggests a failure to
FT                                incorporate the mutant protein in the
FT                                cell membrane).
FT                                /FTId=VAR_002042.
FT   VARIANT      55     55       T -> A (in CMTX1).
FT                                /FTId=VAR_029908.
FT   VARIANT      55     55       T -> I (in CMTX1).
FT                                /FTId=VAR_008137.
FT   VARIANT      55     55       T -> R (in CMTX1).
FT                                /FTId=VAR_029909.
FT   VARIANT      56     56       L -> F (in CMTX1; functional channel).
FT                                /FTId=VAR_002043.
FT   VARIANT      57     57       Q -> H (in CMTX1).
FT                                /FTId=VAR_029910.
FT   VARIANT      58     58       P -> R (in CMT-1).
FT                                /FTId=VAR_002044.
FT   VARIANT      59     59       G -> C (in CMTX1).
FT                                /FTId=VAR_002045.
FT   VARIANT      59     59       G -> R (in CMTX1).
FT                                /FTId=VAR_029911.
FT   VARIANT      60     60       C -> F (in CMTX1; moderate).
FT                                /FTId=VAR_002046.
FT   VARIANT      63     63       V -> I (in CMTX1; can be associated with
FT                                Gln-22).
FT                                /FTId=VAR_002047.
FT   VARIANT      64     64       C -> F (in CMTX1; moderate).
FT                                /FTId=VAR_029912.
FT   VARIANT      64     64       C -> S (in CMTX1).
FT                                /FTId=VAR_002048.
FT   VARIANT      65     65       Y -> C (in CMTX1).
FT                                /FTId=VAR_002049.
FT   VARIANT      65     65       Y -> H (in CMTX1).
FT                                /FTId=VAR_012313.
FT   VARIANT      66     66       Missing (in CMTX1).
FT                                /FTId=VAR_002050.
FT   VARIANT      69     69       F -> L (in CMTX1).
FT                                /FTId=VAR_029913.
FT   VARIANT      70     70       P -> A (in CMTX1).
FT                                /FTId=VAR_029914.
FT   VARIANT      75     75       R -> P (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_002051.
FT   VARIANT      75     75       R -> Q (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_002052.
FT   VARIANT      75     75       R -> W (in CMTX1; localized in the Golgi
FT                                apparatus without reaching the cell
FT                                membrane).
FT                                /FTId=VAR_002053.
FT   VARIANT      77     77       W -> S (in CMTX1).
FT                                /FTId=VAR_002054.
FT   VARIANT      80     80       Q -> R (in CMTX1).
FT                                /FTId=VAR_002055.
FT   VARIANT      81     81       L -> F (in CMTX1).
FT                                /FTId=VAR_002056.
FT   VARIANT      83     83       L -> P (in CMTX1).
FT                                /FTId=VAR_002057.
FT   VARIANT      84     84       V -> I (in CMTX1).
FT                                /FTId=VAR_002058.
FT   VARIANT      85     85       S -> C (in CMTX1; mutant have a higher
FT                                open probability than hemichannels formed
FT                                of GJB1 wild-type).
FT                                /FTId=VAR_002059.
FT   VARIANT      85     85       S -> F (in CMTX1).
FT                                /FTId=VAR_002060.
FT   VARIANT      86     86       T -> A (in CMTX1; moderate).
FT                                /FTId=VAR_002061.
FT   VARIANT      86     86       T -> N (in CMTX1).
FT                                /FTId=VAR_002062.
FT   VARIANT      86     86       T -> S (in CMTX1).
FT                                /FTId=VAR_002063.
FT   VARIANT      87     87       P -> A (in CMTX1).
FT                                /FTId=VAR_002064.
FT   VARIANT      87     87       P -> L (in CMTX1).
FT                                /FTId=VAR_002065.
FT   VARIANT      87     87       P -> S (in CMTX1).
FT                                /FTId=VAR_002066.
FT   VARIANT      89     89       L -> P (in CMTX1).
FT                                /FTId=VAR_002067.
FT   VARIANT      90     90       L -> H (in CMTX1).
FT                                /FTId=VAR_002068.
FT   VARIANT      90     90       L -> V (in CMTX1).
FT                                /FTId=VAR_029915.
FT   VARIANT      91     91       V -> M (in CMTX1).
FT                                /FTId=VAR_029916.
FT   VARIANT      93     93       M -> V (in CMTX1).
FT                                /FTId=VAR_002069.
FT   VARIANT      94     94       H -> D (in CMTX1).
FT                                /FTId=VAR_029917.
FT   VARIANT      94     94       H -> Q (in CMTX1; non-functional
FT                                channel).
FT                                /FTId=VAR_002070.
FT   VARIANT      94     94       H -> Y (in CMTX1).
FT                                /FTId=VAR_002071.
FT   VARIANT      95     95       V -> M (in CMTX1; non-functional
FT                                channel).
FT                                /FTId=VAR_002072.
FT   VARIANT     100    100       H -> Y (in CMTX1; mild/moderate).
FT                                /FTId=VAR_002073.
FT   VARIANT     102    102       E -> G (in CMTX1; mild phenotype;
FT                                increased sensitivity to acidification-
FT                                induced closure).
FT                                /FTId=VAR_002074.
FT   VARIANT     102    102       Missing (in CMTX1).
FT                                /FTId=VAR_029918.
FT   VARIANT     103    103       K -> E (in CMTX1).
FT                                /FTId=VAR_002075.
FT   VARIANT     104    104       K -> T (in CMTX1).
FT                                /FTId=VAR_029919.
FT   VARIANT     107    107       R -> W (in CMTX1).
FT                                /FTId=VAR_002076.
FT   VARIANT     108    108       L -> P (in CMTX1).
FT                                /FTId=VAR_029920.
FT   VARIANT     111    116       Missing (in CMTX1).
FT                                /FTId=VAR_002077.
FT   VARIANT     120    120       V -> E (in CMTX1).
FT                                /FTId=VAR_008138.
FT   VARIANT     120    120       Missing (in CMTX1).
FT                                /FTId=VAR_029921.
FT   VARIANT     124    124       K -> N (in CMTX1).
FT                                /FTId=VAR_002078.
FT   VARIANT     125    125       V -> D (in CMTX1).
FT                                /FTId=VAR_029922.
FT   VARIANT     126    126       H -> Y (in CMTX1).
FT                                /FTId=VAR_029923.
FT   VARIANT     127    127       I -> M (in CMTX1).
FT                                /FTId=VAR_029924.
FT   VARIANT     127    127       I -> S (in CMTX1).
FT                                /FTId=VAR_029925.
FT   VARIANT     128    128       S -> P (in CMTX1).
FT                                /FTId=VAR_002079.
FT   VARIANT     130    130       T -> I (in CMTX1).
FT                                /FTId=VAR_029926.
FT   VARIANT     131    131       L -> P (in CMTX1).
FT                                /FTId=VAR_029927.
FT   VARIANT     133    133       W -> C (in CMTX1; moderate).
FT                                /FTId=VAR_002080.
FT   VARIANT     133    133       W -> R (in CMTX1).
FT                                /FTId=VAR_002081.
FT   VARIANT     135    135       Y -> C (in CMTX1).
FT                                /FTId=VAR_002082.
FT   VARIANT     136    136       V -> A (in CMTX1; demyelinating form;
FT                                associated with W-359 in the EGR2 gene in
FT                                a DSS Korean girl).
FT                                /FTId=VAR_021611.
FT   VARIANT     138    138       S -> N (in CMTX1).
FT                                /FTId=VAR_029928.
FT   VARIANT     139    139       V -> M (in CMTX1).
FT                                /FTId=VAR_002083.
FT   VARIANT     141    141       F -> L (in CMTX1).
FT                                /FTId=VAR_002084.
FT   VARIANT     142    142       R -> E (in CMTX1; requires 2 nucleotide
FT                                substitutions).
FT                                /FTId=VAR_002085.
FT   VARIANT     142    142       R -> Q (in CMTX1).
FT                                /FTId=VAR_029929.
FT   VARIANT     142    142       R -> W (in CMTX1; moderate).
FT                                /FTId=VAR_002086.
FT   VARIANT     143    143       Missing (in CMTX1).
FT                                /FTId=VAR_002087.
FT   VARIANT     146    146       E -> K (in CMTX1).
FT                                /FTId=VAR_029930.
FT   VARIANT     147    147       A -> D (in CMTX1).
FT                                /FTId=VAR_029931.
FT   VARIANT     149    149       F -> I (in CMTX1).
FT                                /FTId=VAR_002088.
FT   VARIANT     149    149       F -> V (in CMTX1; pathogenicity
FT                                uncertain).
FT                                /FTId=VAR_029932.
FT   VARIANT     151    151       Y -> S (in CMTX1).
FT                                /FTId=VAR_029933.
FT   VARIANT     153    153       F -> S (in CMTX1).
FT                                /FTId=VAR_029934.
FT   VARIANT     156    156       L -> F (in CMTX1).
FT                                /FTId=VAR_002089.
FT   VARIANT     156    156       L -> R (in CMTX1).
FT                                /FTId=VAR_002090.
FT   VARIANT     157    157       Y -> C (in CMTX1).
FT                                /FTId=VAR_002091.
FT   VARIANT     158    158       P -> A (in CMTX1).
FT                                /FTId=VAR_002092.
FT   VARIANT     158    158       P -> R (in CMTX1).
FT                                /FTId=VAR_002093.
FT   VARIANT     158    158       P -> S (in CMTX1).
FT                                /FTId=VAR_002094.
FT   VARIANT     159    159       G -> D (in CMTX1).
FT                                /FTId=VAR_029935.
FT   VARIANT     159    159       G -> S (in CMTX1).
FT                                /FTId=VAR_002095.
FT   VARIANT     160    160       Y -> H (in CMTX1).
FT                                /FTId=VAR_002096.
FT   VARIANT     161    161       A -> P (in CMTX1).
FT                                /FTId=VAR_002097.
FT   VARIANT     164    164       R -> Q (in CMTX1).
FT                                /FTId=VAR_002098.
FT   VARIANT     164    164       R -> W (in CMTX1; moderate).
FT                                /FTId=VAR_002099.
FT   VARIANT     168    168       C -> R (in CMTX1; demyelinating form).
FT                                /FTId=VAR_021612.
FT   VARIANT     168    168       C -> Y (in CMTX1).
FT                                /FTId=VAR_029936.
FT   VARIANT     172    172       P -> A (in CMTX1; suggests a failure to
FT                                incorporate the mutant protein in the
FT                                cell membrane).
FT                                /FTId=VAR_029937.
FT   VARIANT     172    172       P -> L (in CMTX1).
FT                                /FTId=VAR_002100.
FT   VARIANT     172    172       P -> R (in CMTX1).
FT                                /FTId=VAR_029938.
FT   VARIANT     172    172       P -> S (in CMTX1).
FT                                /FTId=VAR_002101.
FT   VARIANT     173    173       C -> R (in CMTX1).
FT                                /FTId=VAR_002102.
FT   VARIANT     175    175       N -> D (in CMT-1).
FT                                /FTId=VAR_002103.
FT   VARIANT     177    177       V -> A (in CMTX1).
FT                                /FTId=VAR_029939.
FT   VARIANT     177    177       V -> E (in CMTX1).
FT                                /FTId=VAR_029940.
FT   VARIANT     178    178       D -> Y (in CMTX1).
FT                                /FTId=VAR_002104.
FT   VARIANT     179    179       C -> R (in CMTX1).
FT                                /FTId=VAR_002105.
FT   VARIANT     180    180       F -> L (in CMTX1).
FT                                /FTId=VAR_002106.
FT   VARIANT     180    180       F -> S (in CMTX1).
FT                                /FTId=VAR_029941.
FT   VARIANT     181    181       V -> A (in CMTX1; profoundly impaired in
FT                                their ability to support the earliest
FT                                stages of regeneration of myelinated
FT                                fibers).
FT                                /FTId=VAR_029942.
FT   VARIANT     181    181       V -> M (in CMTX1).
FT                                /FTId=VAR_002107.
FT   VARIANT     182    182       S -> T (in CMTX1).
FT                                /FTId=VAR_002108.
FT   VARIANT     183    183       R -> C (in CMTX1).
FT                                /FTId=VAR_002109.
FT   VARIANT     183    183       R -> H (in CMTX1).
FT                                /FTId=VAR_002110.
FT   VARIANT     183    183       R -> S (in CMTX1).
FT                                /FTId=VAR_002111.
FT   VARIANT     184    184       P -> L (in CMTX1).
FT                                /FTId=VAR_029943.
FT   VARIANT     184    184       P -> R (in CMTX1).
FT                                /FTId=VAR_002112.
FT   VARIANT     185    185       Missing (in CMTX1).
FT                                /FTId=VAR_002113.
FT   VARIANT     186    186       E -> K (in CMTX1; non-functional
FT                                channel).
FT                                /FTId=VAR_002114.
FT   VARIANT     187    187       K -> E (in CMTX1).
FT                                /FTId=VAR_002115.
FT   VARIANT     189    189       V -> G (in CMTX1).
FT                                /FTId=VAR_002116.
FT   VARIANT     189    189       V -> I (in CMTX1).
FT                                /FTId=VAR_002117.
FT   VARIANT     191    193       Missing (in CMTX1).
FT                                /FTId=VAR_002118.
FT   VARIANT     191    191       T -> A (in CMTX1).
FT                                /FTId=VAR_029944.
FT   VARIANT     192    192       V -> F (in CMTX1).
FT                                /FTId=VAR_029945.
FT   VARIANT     193    193       F -> C (in CMTX1).
FT                                /FTId=VAR_002119.
FT   VARIANT     193    193       F -> L (in CMTX1).
FT                                /FTId=VAR_029946.
FT   VARIANT     194    194       M -> V (in CMTX1).
FT                                /FTId=VAR_002120.
FT   VARIANT     198    198       S -> F (in CMTX1).
FT                                /FTId=VAR_002121.
FT   VARIANT     199    199       G -> R (in CMTX1).
FT                                /FTId=VAR_002122.
FT   VARIANT     201    201       C -> R (in CMTX1; severe).
FT                                /FTId=VAR_002123.
FT   VARIANT     201    201       C -> Y (in CMTX1).
FT                                /FTId=VAR_029947.
FT   VARIANT     203    203       I -> N (in CMTX1).
FT                                /FTId=VAR_002124.
FT   VARIANT     204    204       L -> F (in CMTX1).
FT                                /FTId=VAR_002125.
FT   VARIANT     204    204       L -> V (in CMTX1).
FT                                /FTId=VAR_029948.
FT   VARIANT     205    205       N -> I (in CMTX1; localized to the
FT                                endoplasmic reticulum).
FT                                /FTId=VAR_029949.
FT   VARIANT     205    205       N -> S (in CMTX1; mild).
FT                                /FTId=VAR_002126.
FT   VARIANT     208    208       E -> G (in CMTX1).
FT                                /FTId=VAR_029950.
FT   VARIANT     208    208       E -> K (in CMTX1; non-detectable levels
FT                                of hemichannel activation and non-
FT                                detectable levels of electrical
FT                                coupling).
FT                                /FTId=VAR_002127.
FT   VARIANT     209    209       Missing (in CMTX1).
FT                                /FTId=VAR_029951.
FT   VARIANT     211    211       Y -> H (in CMTX1).
FT                                /FTId=VAR_029952.
FT   VARIANT     213    214       II -> L (in CMTX1).
FT                                /FTId=VAR_002128.
FT   VARIANT     213    213       I -> V (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_029953.
FT   VARIANT     215    215       R -> Q (in CMTX1; non-detectable levels
FT                                of hemichannel activation and non-
FT                                detectable levels of electrical
FT                                coupling).
FT                                /FTId=VAR_029954.
FT   VARIANT     215    215       R -> W (in CMTX1; mild/moderate; non-
FT                                functional channel).
FT                                /FTId=VAR_002129.
FT   VARIANT     219    219       R -> C (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002130.
FT   VARIANT     219    219       R -> H (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002131.
FT   VARIANT     220    220       R -> G (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002132.
FT   VARIANT     230    230       R -> C (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002133.
FT   VARIANT     230    230       R -> L (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002134.
FT   VARIANT     235    235       F -> C (in CMTX1; the mutation causes
FT                                abnormal hemichannel opening with
FT                                excessive permeability of the plasma
FT                                membrane and decreased cell survival).
FT                                /FTId=VAR_002135.
FT   VARIANT     238    238       R -> H (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_002136.
FT   VARIANT     239    239       L -> I (in CMTX1; localized mainly on the
FT                                cell membrane forming gap junction-like
FT                                plaques).
FT                                /FTId=VAR_029955.
FT   VARIANT     264    264       R -> C (in CMTX1).
FT                                /FTId=VAR_029956.
FT   VARIANT     280    280       C -> G (in CMTX1; forms channels
FT                                normally).
FT                                /FTId=VAR_029957.
FT   CONFLICT     16     17       HS -> IL (in Ref. 6; AAA75086).
SQ   SEQUENCE   283 AA;  32025 MW;  8222C4811D12451E CRC64;
     MNWTGLYTLL SGVNRHSTAI GRVWLSVIFI FRIMVLVVAA ESVWGDEKSS FICNTLQPGC
     NSVCYDQFFP ISHVRLWSLQ LILVSTPALL VAMHVAHQQH IEKKMLRLEG HGDPLHLEEV
     KRHKVHISGT LWWTYVISVV FRLLFEAVFM YVFYLLYPGY AMVRLVKCDV YPCPNTVDCF
     VSRPTEKTVF TVFMLAASGI CIILNVAEVV YLIIRACARR AQRRSNPPSR KGSGFGHRLS
     PEYKQNEINK LLSEQDGSLK DILRRSPGTG AGLAEKSDRC SAC
//
